Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT06982521. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT05996107. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy.
ClinicalTrials.gov study NCT02526992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
ClinicalTrials.gov study NCT04791384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects
ClinicalTrials.gov study NCT01258699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
ClinicalTrials.gov study NCT05304962. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors
ClinicalTrials.gov study NCT06243185. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT07086196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC
ClinicalTrials.gov study NCT03858972. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
ClinicalTrials.gov study NCT06611813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multimodal Imaging Evaluation of Vulnerability of Atherosclerotic Plaques: A Comparison of HR-VWI, OCT, and RWS
ClinicalTrials.gov study NCT07133451. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT05633914. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open
ClinicalTrials.gov study NCT05165225. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research
ClinicalTrials.gov study NCT05885776. IPD Sharing: YES. Countries: 1. Publications: 0.
Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
ClinicalTrials.gov study NCT06837792. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients
ClinicalTrials.gov study NCT01446185. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection
ClinicalTrials.gov study NCT01022346. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Radiotherapy
ClinicalTrials.gov study NCT07005882. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Efficacy of Allo-HSCT in ND HR-CBF-AML
ClinicalTrials.gov study NCT06458244. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer
ClinicalTrials.gov study NCT05430347. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.